Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Guelph

$25,000.00

Developing a microfluidic system for sensitive, rapid, multiplexed protein quantification using a gold-nanoparticle-embedded membrane platform

EF 2024-25

Résumé
The proposed research project involves a collaboration between Dr. Huiyan Li's laboratory at the University of Guelph (Guelph, Ontario, Canada) and Dr. Ayokunle Olanrewaju's laboratory at the University of Washington (Seattle, Washington, USA). We aim to develop a microfluidic system that integrates with Dr Li's highly sensitive protein quantification platform. The integrated platform will drastically reduce the time to analyze protein levels in biofluids, such as blood plasma, enabling fast and sensitive disease detection for conditions requiring urgent treatment. Proteins are vital components in the body, performing various functions. Measuring specific protein concentrations in biological fluids provides crucial insights into health and disease. However, disease-related proteins are often present at low concentrations in blood, making them challenging to detect. Certain disease like sepsis even requires urgent treatment within a critical three-hour window. Dr. Li's laboratory has recently developed a gold-nanoparticle-embedded membrane (GEM) technology, capable of multiplexed protein measurement with a thousand-fold higher sensitivity than conventional methods, suitable for analyzing low-abundant proteins for early disease diagnostics. However, the current assay procedure takes over 5 hours, leading to long turnaround times. In this collaboration, we will leverage Dr. Olanrewaju's expertise in microfluidics to develop and integrate a microfluidic system into the GEM platform to reduce the assay time to under 30 minutes. The project will result in a pioneering protein analysis tool with exceptional sensitivity, multiplexing capability, and rapid sample-to-result turnaround, facilitating timely and accurate diagnosis of diseases like sepsis that require urgent treatment. The implications of this research are significant for Canada's biotechnology sector. The innovative protein analysis tool has the potential to benefit biotechnology sectors, driving forward innovation and competitiveness in the industry. Furthermore, by training Highly Qualified Personnel (HQP) in biosensing and microfluidics, we contribute to the long-term sustainability and growth of the Canadian biotech industry.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
597025-2024
Name nom
Li, Huiyan H
Department département
Engineering, School of
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Developing a microfluidic system for sensitive, rapid, multiplexed protein quantification using a gold-nanoparticle-embedded membrane platform
Keywords
assay sensitivity; compartments; gold nanoparticles; membrane; microfluidic system; multiplexed immunoassays; rapid immunoassays; sample-to-result time
Application summary
The proposed research project involves a collaboration between Dr. Huiyan Li's laboratory at the University of Guelph (Guelph, Ontario, Canada) and Dr. Ayokunle Olanrewaju's laboratory at the University of Washington (Seattle, Washington, USA). We aim to develop a microfluidic system that integrates with Dr Li's highly sensitive protein quantification platform. The integrated platform will drastically reduce the time to analyze protein levels in biofluids, such as blood plasma, enabling fast and sensitive disease detection for conditions requiring urgent treatment. Proteins are vital components in the body, performing various functions. Measuring specific protein concentrations in biological fluids provides crucial insights into health and disease. However, disease-related proteins are often present at low concentrations in blood, making them challenging to detect. Certain disease like sepsis even requires urgent treatment within a critical three-hour window. Dr. Li's laboratory has recently developed a gold-nanoparticle-embedded membrane (GEM) technology, capable of multiplexed protein measurement with a thousand-fold higher sensitivity than conventional methods, suitable for analyzing low-abundant proteins for early disease diagnostics. However, the current assay procedure takes over 5 hours, leading to long turnaround times. In this collaboration, we will leverage Dr. Olanrewaju's expertise in microfluidics to develop and integrate a microfluidic system into the GEM platform to reduce the assay time to under 30 minutes. The project will result in a pioneering protein analysis tool with exceptional sensitivity, multiplexing capability, and rapid sample-to-result turnaround, facilitating timely and accurate diagnosis of diseases like sepsis that require urgent treatment. The implications of this research are significant for Canada's biotechnology sector. The innovative protein analysis tool has the potential to benefit biotechnology sectors, driving forward innovation and competitiveness in the industry. Furthermore, by training Highly Qualified Personnel (HQP) in biosensing and microfluidics, we contribute to the long-term sustainability and growth of the Canadian biotech industry.